Abrahamsson, H., Porojnicu, A. C., Lindstrøm, J. C., Dueland, S., Flatmark, K., Hole, K. H., . . . Ree, A. H. (2019). High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer. BMC Cancer.
Citación estilo ChicagoAbrahamsson, Hanna, et al. "High Level of Circulating Vitamin D During Neoadjuvant Therapy May Lower Risk of Metastatic Progression in High-risk Rectal Cancer." BMC Cancer 2019.
Cita MLAAbrahamsson, Hanna, et al. "High Level of Circulating Vitamin D During Neoadjuvant Therapy May Lower Risk of Metastatic Progression in High-risk Rectal Cancer." BMC Cancer 2019.
Precaución: Estas citas no son 100% exactas.